Audicus Omni 2 vs Resound Vivia 9 60S microRIE

The Audicus Omni 2 is a premium behind-the-ear OTC hearing aid priced at $1,898 that earned an A grade in our lab testing, placing it in the top 6% of the 65 OTC hearing aids we've evaluated. This two-time Expert's Choice Award winner (2023 and 2024) delivers consistently strong performance across multiple listening scenarios. In our testing, the Omni 2 demonstrated particular strength in speech clarity during quiet environments, scoring 4.2/5—a strong result that sits 1.38 points above the category average. Music streaming quality also impressed at 3.6/5, exceeding the category average by 1.68 points. Speech understanding in noisy environments scored 2.3/5, which is above the category average of 1.48 but represents mixed performance in absolute terms—meaning challenging noise situations may still prove difficult. The device offers flexible power options with both rechargeable and disposable batteries, and supports streaming from both iPhone and Android devices with hands-free capability. Feedback handling is excellent at 4.5/5, essentially matching the category average, while own-voice comfort scores a solid 3.0/5. The Audicus Omni 2 is best suited for consumers seeking a premium OTC option with strong everyday speech clarity and quality streaming capabilities. Those frequently in very noisy environments should set realistic expectations, though the device still outperforms most OTC competitors in these conditions.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.